Refik Pul

4.0k total citations
94 papers, 2.2k citations indexed

About

Refik Pul is a scholar working on Pathology and Forensic Medicine, Neurology and Immunology. According to data from OpenAlex, Refik Pul has authored 94 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pathology and Forensic Medicine, 25 papers in Neurology and 24 papers in Immunology. Recurrent topics in Refik Pul's work include Multiple Sclerosis Research Studies (38 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers) and Peripheral Neuropathies and Disorders (18 papers). Refik Pul is often cited by papers focused on Multiple Sclerosis Research Studies (38 papers), Neuroinflammation and Neurodegeneration Mechanisms (20 papers) and Peripheral Neuropathies and Disorders (18 papers). Refik Pul collaborates with scholars based in Germany, United States and Switzerland. Refik Pul's co-authors include Martin Stangel, Thomas Skripuletz, Viktoria Gudi, Elke Voß, Jelena Škuljec, Corinna Trebst, Christoph Kleinschnitz, Darius Moharregh-Khiabani, Kurt‐Wolfram Sühs and Wolfgang Baumgärtner and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Brain.

In The Last Decade

Refik Pul

89 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Refik Pul Germany 26 764 708 509 493 434 94 2.2k
Isabella Wimmer Austria 18 990 1.3× 1.1k 1.5× 653 1.3× 541 1.1× 250 0.6× 25 2.3k
Arnon Karni Israel 26 494 0.6× 846 1.2× 449 0.9× 723 1.5× 236 0.5× 92 2.6k
Catherine Larochelle Canada 25 623 0.8× 579 0.8× 498 1.0× 614 1.2× 180 0.4× 60 1.9k
Shalina S. Ousman Canada 21 728 1.0× 497 0.7× 1.0k 2.0× 748 1.5× 335 0.8× 40 2.8k
Djordje Gverić United Kingdom 19 816 1.1× 708 1.0× 598 1.2× 783 1.6× 273 0.6× 27 2.5k
Tobias Zrzavy Austria 15 741 1.0× 855 1.2× 370 0.7× 431 0.9× 186 0.4× 48 1.7k
Amanda Boyd United Kingdom 15 980 1.3× 418 0.6× 561 1.1× 622 1.3× 670 1.5× 19 2.2k
Azeb Tadesse Argaw United States 14 1.1k 1.4× 213 0.3× 724 1.4× 341 0.7× 298 0.7× 16 2.2k
Francesca Odoardi Germany 24 1.1k 1.4× 581 0.8× 630 1.2× 1.2k 2.5× 194 0.4× 39 2.9k
Barbara Kornek Austria 20 515 0.7× 1.7k 2.4× 557 1.1× 353 0.7× 437 1.0× 58 2.5k

Countries citing papers authored by Refik Pul

Since Specialization
Citations

This map shows the geographic impact of Refik Pul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Refik Pul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Refik Pul more than expected).

Fields of papers citing papers by Refik Pul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Refik Pul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Refik Pul. The network helps show where Refik Pul may publish in the future.

Co-authorship network of co-authors of Refik Pul

This figure shows the co-authorship network connecting the top 25 collaborators of Refik Pul. A scholar is included among the top collaborators of Refik Pul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Refik Pul. Refik Pul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Konen, Franz Felix, Nora Möhn, Torsten Witte, et al.. (2025). Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Autoimmunity Reviews. 24(4). 103754–103754.
2.
Kleinschnitz, Christoph, Jelena Škuljec, Markus C. Kowarik, et al.. (2025). First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions. Multiple Sclerosis and Related Disorders. 97. 106398–106398. 1 indexed citations
3.
Konen, Franz Felix, Steffen Pfeuffer, Klaus Gehring, et al.. (2025). Switching from anti-CD20 therapies to cladribine and vice versa – Analysis of a German relapsing multiple sclerosis cohort. Neurotherapeutics. 23(1). e00812–e00812.
4.
Kowarik, Markus C., Michael Ernst, Lukas Cepek, et al.. (2024). Real-world therapy management of patients with multiple sclerosis receiving cladribine tablets beyond year 4 – Results from a German cladribine cohort. Multiple Sclerosis and Related Disorders. 88. 105704–105704. 5 indexed citations
5.
Mannherz, Hans Georg, Heidi Budde, Natalia Małek, et al.. (2024). Reorganization of the actin cytoskeleton during the formation of neutrophil extracellular traps (NETs). European Journal of Cell Biology. 103(2). 151407–151407. 3 indexed citations
6.
Schwake, Carolin, Ingo Kleiter, Bianca Teegen, et al.. (2024). Cognitive Impairment, Associated Clinical Factors, and MR Volumetric Measures in Myelin Oligodendrocyte Glycoprotein-IgG–Associated Disease. Neurology Neuroimmunology & Neuroinflammation. 11(6). e200325–e200325. 2 indexed citations
7.
Jendretzky, Konstantin Fritz, Franz Felix Konen, André Huss, et al.. (2024). Prevalence of comorbid autoimmune diseases and antibodies in newly diagnosed multiple sclerosis patients. SHILAP Revista de lepidopterología. 6(1). 55–55. 1 indexed citations
8.
Kizina, Kathrin, Daniel Jokisch, Benjamin Stolte, et al.. (2021). Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy. Brain Sciences. 11(9). 1184–1184. 12 indexed citations
9.
Möhn, Nora, Franz Felix Konen, Refik Pul, et al.. (2020). Experience in Multiple Sclerosis Patients with COVID-19 and Disease-Modifying Therapies: A Review of 873 Published Cases. Journal of Clinical Medicine. 9(12). 4067–4067. 46 indexed citations
10.
Wang, Chen, Verena Börger, Maryam Sardari, et al.. (2020). Mesenchymal Stromal Cell–Derived Small Extracellular Vesicles Induce Ischemic Neuroprotection by Modulating Leukocytes and Specifically Neutrophils. Stroke. 51(6). 1825–1834. 117 indexed citations
11.
Schwenkenbecher, Philipp, Lena Bönig, Ulrich Wurster, et al.. (2017). Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis. International Journal of Molecular Sciences. 18(10). 2061–2061. 23 indexed citations
12.
Pul, Refik, Alma Osmanovic, Amelie Pielen, et al.. (2016). Fingolimod Associated Bilateral Cystoid Macular Edema—Wait and See?. International Journal of Molecular Sciences. 17(12). 2106–2106. 8 indexed citations
13.
Schwenkenbecher, Philipp, Ulrich Wurster, Paul Bronzlik, et al.. (2016). McDonald Criteria 2010 and 2005 Compared: Persistence of High Oligoclonal Band Prevalence Despite Almost Doubled Diagnostic Sensitivity. International Journal of Molecular Sciences. 17(9). 1592–1592. 33 indexed citations
14.
Sühs, Kurt‐Wolfram, Panagiotis Papanagiotou, Katharina Hein, et al.. (2016). Disease Activity and Conversion into Multiple Sclerosis after Optic Neuritis Is Treated with Erythropoietin. International Journal of Molecular Sciences. 17(10). 1666–1666. 5 indexed citations
15.
Pul, Refik, Özlem Kayım Yıldız, Thomas Skripuletz, et al.. (2015). CSF Levels of Angiopoietin-2 Do Not Differ between Patients with CSF Fluid Leakage Syndrome and Controls. Disease Markers. 2015. 1–9. 2 indexed citations
16.
Kahl, Kai G., Ulrich Schweiger, Matthias Gutberlet, et al.. (2014). Pericardial, intra‐abdominal, and subcutaneous adipose tissue in patients with major depressive disorder. Acta Psychiatrica Scandinavica. 130(2). 137–143. 22 indexed citations
17.
Gudi, Viktoria, Chittappen Kandiyil Prajeeth, Vikramjeet Singh, et al.. (2014). A pivotal role of nonmuscle myosin II during microglial activation. Experimental Neurology. 261. 666–676. 13 indexed citations
18.
Skripuletz, Thomas, Philipp Schwenkenbecher, Kaweh Pars, et al.. (2014). Importance of Follow-Up Cerebrospinal Fluid Analysis in Cryptococcal Meningoencephalitis. Disease Markers. 2014. 1–10. 26 indexed citations
19.
Skripuletz, Thomas, Arndt Manzel, Viktoria Gudi, et al.. (2014). Pivotal role of choline metabolites in remyelination. Brain. 138(2). 398–413. 77 indexed citations
20.
Skripuletz, Thomas, Darius Moharregh-Khiabani, Refik Pul, et al.. (2010). Beneficial Effects of Minocycline on Cuprizone Induced Cortical Demyelination. Neurochemical Research. 35(9). 1422–1433. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabella Wimmer Breakdown of academic impact, for papers by Arnon Karni Breakdown of academic impact, for papers by Catherine Larochelle Breakdown of academic impact, for papers by Shalina S. Ousman Breakdown of academic impact, for papers by Djordje Gverić Breakdown of academic impact, for papers by Tobias Zrzavy Breakdown of academic impact, for papers by Amanda Boyd Breakdown of academic impact, for papers by Azeb Tadesse Argaw Breakdown of academic impact, for papers by Francesca Odoardi Breakdown of academic impact, for papers by Barbara Kornek
Rankless by CCL
2026